JP2019534003A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019534003A5 JP2019534003A5 JP2019521455A JP2019521455A JP2019534003A5 JP 2019534003 A5 JP2019534003 A5 JP 2019534003A5 JP 2019521455 A JP2019521455 A JP 2019521455A JP 2019521455 A JP2019521455 A JP 2019521455A JP 2019534003 A5 JP2019534003 A5 JP 2019534003A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- adi
- nos
- antigen
- rsv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022066241A JP2022087247A (ja) | 2016-10-21 | 2022-04-13 | 抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法 |
| JP2023146398A JP7616813B2 (ja) | 2016-10-21 | 2023-09-08 | 抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法 |
| JP2023146397A JP2023158193A (ja) | 2016-10-21 | 2023-09-08 | 抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662411510P | 2016-10-21 | 2016-10-21 | |
| US62/411,510 | 2016-10-21 | ||
| PCT/US2017/057708 WO2018075954A2 (en) | 2016-10-21 | 2017-10-20 | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022066241A Division JP2022087247A (ja) | 2016-10-21 | 2022-04-13 | 抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019534003A JP2019534003A (ja) | 2019-11-28 |
| JP2019534003A5 true JP2019534003A5 (enExample) | 2020-11-26 |
| JP7265984B2 JP7265984B2 (ja) | 2023-04-27 |
Family
ID=60263072
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019521455A Active JP7265984B2 (ja) | 2016-10-21 | 2017-10-20 | 抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法 |
| JP2022066241A Withdrawn JP2022087247A (ja) | 2016-10-21 | 2022-04-13 | 抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法 |
| JP2023146398A Active JP7616813B2 (ja) | 2016-10-21 | 2023-09-08 | 抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法 |
| JP2023146397A Withdrawn JP2023158193A (ja) | 2016-10-21 | 2023-09-08 | 抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022066241A Withdrawn JP2022087247A (ja) | 2016-10-21 | 2022-04-13 | 抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法 |
| JP2023146398A Active JP7616813B2 (ja) | 2016-10-21 | 2023-09-08 | 抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法 |
| JP2023146397A Withdrawn JP2023158193A (ja) | 2016-10-21 | 2023-09-08 | 抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (3) | US11479600B2 (enExample) |
| EP (1) | EP3529272A2 (enExample) |
| JP (4) | JP7265984B2 (enExample) |
| WO (1) | WO2018075954A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3529272A2 (en) | 2016-10-21 | 2019-08-28 | Adimab, LLC | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| KR102695416B1 (ko) | 2016-10-21 | 2024-08-13 | 아디맵 엘엘씨 | 항-호흡기 세포융합 바이러스 항체, 그리고 이의 생성 방법 및 사용 방법 |
| CA3040893A1 (en) | 2016-10-21 | 2018-04-26 | Adimab, Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| CN112300279A (zh) * | 2019-07-26 | 2021-02-02 | 上海复宏汉霖生物技术股份有限公司 | 针对抗cd73抗体和变体的方法和组合物 |
| US20240101648A1 (en) * | 2021-02-09 | 2024-03-28 | Humabs Biomed Sa | Antibodies against respiratory syncytial virus, human metapneumovirus and pneumonia virus of mice and methods of using the same |
| CN119264248A (zh) * | 2022-07-22 | 2025-01-07 | 北京智仁美博生物科技有限公司 | 抗呼吸道合胞病毒中和性抗体及其用途 |
| EP4562034A1 (en) * | 2022-07-27 | 2025-06-04 | Humabs Biomed SA | Broadly neutralizing antibodies against rsv and mpv paramyxoviruses |
| CN119546630A (zh) * | 2022-12-08 | 2025-02-28 | 南京诺唯赞生物科技股份有限公司 | 特异性结合rsv的抗体 |
| CN118108812B (zh) * | 2023-05-04 | 2025-04-15 | 国药中生生物技术研究院有限公司 | Rsv f蛋白的突变体 |
| WO2024259075A1 (en) * | 2023-06-14 | 2024-12-19 | Tether Therapeutics, Inc. | Polymer formulations for delivery of polynucleotides |
| WO2025104604A1 (en) * | 2023-11-14 | 2025-05-22 | Janssen Pharmaceuticals, Inc. | Anti-respiratory syncytial virus antibodies and uses thereof |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5824307A (en) | 1991-12-23 | 1998-10-20 | Medimmune, Inc. | Human-murine chimeric antibodies against respiratory syncytial virus |
| DK0671927T3 (da) | 1992-09-16 | 2003-04-22 | Us Gov Health & Human Serv | Neutraliserende humane monoklonale antistoffer mod respiratorisk syncytialvirus |
| WO1995004081A1 (en) | 1993-07-30 | 1995-02-09 | Oravax, Inc. | MONOCLONAL IgA ANTIBODY AGAINST RESPIRATORY SYNCYTIAL VIRUS |
| US5811524A (en) | 1995-06-07 | 1998-09-22 | Idec Pharmaceuticals Corporation | Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| ATE194291T1 (de) | 1995-09-18 | 2000-07-15 | Intracel Corp | Neutralisierende monoklonale antikörper gegen respiratorischen synzytialvirus |
| US20020141990A1 (en) | 1996-11-01 | 2002-10-03 | Smithkline Beecham Corporation | Anti-RSV human monoclonal antibodies |
| MXPA02004193A (es) | 1999-10-29 | 2002-12-13 | Inhale Therapeutic Syst | Composiciones de polvo seco que tienen caracteristicas de dispersion mejoradas. |
| CA2398466A1 (en) | 2000-01-27 | 2001-08-02 | Medimmune, Inc. | Ultra high affinity neutralizing antibodies |
| US7229619B1 (en) | 2000-11-28 | 2007-06-12 | Medimmune, Inc. | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| AU4002001A (en) | 2000-03-01 | 2001-09-12 | Med Immune Inc | High potency recombinant antibodies and method for producing them |
| US6565849B2 (en) | 2000-03-02 | 2003-05-20 | Medimmune, Inc. | Methods of enhancing activity of vaccines and vaccine compositions |
| WO2001082966A1 (en) | 2000-05-03 | 2001-11-08 | Medimmune, Inc. | Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US6818216B2 (en) | 2000-11-28 | 2004-11-16 | Medimmune, Inc. | Anti-RSV antibodies |
| US6855493B2 (en) | 2000-11-28 | 2005-02-15 | Medimmune, Inc. | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| US7179900B2 (en) | 2000-11-28 | 2007-02-20 | Medimmune, Inc. | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| US7658921B2 (en) | 2000-12-12 | 2010-02-09 | Medimmune, Llc | Molecules with extended half-lives, compositions and uses thereof |
| JP4336498B2 (ja) | 2000-12-12 | 2009-09-30 | メディミューン，エルエルシー | 延長した半減期を有する分子ならびにその組成物および用途 |
| US7425618B2 (en) | 2002-06-14 | 2008-09-16 | Medimmune, Inc. | Stabilized anti-respiratory syncytial virus (RSV) antibody formulations |
| US20040101920A1 (en) | 2002-11-01 | 2004-05-27 | Czeslaw Radziejewski | Modification assisted profiling (MAP) methodology |
| EP1613261A4 (en) | 2003-04-09 | 2011-01-26 | Novo Nordisk As | INTRA-CELLULAR FORMATION OF PEPTIDE CONJUGATES |
| JP2007526208A (ja) | 2003-04-11 | 2007-09-13 | メディミューン，インコーポレーテッド | 呼吸器の症状を治療又は予防する方法 |
| US7070786B2 (en) | 2003-06-06 | 2006-07-04 | Centocor, Inc. | RSV proteins, antibodies, compositions, methods and uses |
| WO2005103081A2 (en) | 2004-04-20 | 2005-11-03 | Genmab A/S | Human monoclonal antibodies against cd20 |
| AU2005286770A1 (en) | 2004-09-21 | 2006-03-30 | Medimmune, Llc | Antibodies against and methods for producing vaccines for respiratory syncytial virus |
| CA2600844A1 (en) | 2005-03-14 | 2006-09-21 | Medimmune, Inc. | Macromolecules comprising a thioether cross-link |
| EP2059532B1 (en) | 2006-09-07 | 2012-12-26 | Crucell Holland B.V. | Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof |
| MX2009009226A (es) | 2007-03-06 | 2009-10-28 | Symphogen As | Anticuerpos recombinantes para el tratamiento de infecciones con el virus respiratorio sincitial. |
| EP1997830A1 (en) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
| RU2010113510A (ru) | 2007-09-07 | 2011-10-20 | Симфоген А/С (Dk) | Способы рекомбинантной продукции антител против респираторно-цинцитиального вируса (rsv) |
| EP2201040A1 (en) | 2007-09-24 | 2010-06-30 | Vanderbilt University | Monoclonal antibodies to respiratory syncytial virus and uses thereof |
| KR100938998B1 (ko) | 2008-01-08 | 2010-01-28 | (주) 에이프로젠 | 호흡기 신시티움 바이러스에 대한 항체 |
| JP5575377B2 (ja) | 2008-07-18 | 2014-08-20 | シスメックス株式会社 | 抗ｒｓウイルスモノクローナル抗体を用いたｒｓウイルス検出用キット及びイムノクロマトグラフィー用試験具、並びに新規な抗ｒｓウイルスモノクローナル抗体 |
| AU2010205627B2 (en) | 2009-01-14 | 2015-04-02 | Ablynx Nv | Pulmonary administration of immunoglobulin single variable domains and constructs thereof |
| KR101852204B1 (ko) | 2009-06-05 | 2018-04-26 | 아블린쓰 엔.브이. | 기도 감염의 예방 및/또는 치료를 위한 일가, 이가 및 삼가 항 인간 호흡기 세포융합 바이러스 (ｈｒｓｖ) 나노바디 구조물 |
| US8568726B2 (en) | 2009-10-06 | 2013-10-29 | Medimmune Limited | RSV specific binding molecule |
| WO2011050168A2 (en) | 2009-10-21 | 2011-04-28 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic | Rsv immunogens, antibodies and compositions thereof |
| ES2778899T3 (es) | 2013-02-01 | 2020-08-12 | Medimmune Llc | Epítopos de proteína F del virus sincitial respiratorio |
| TWI659968B (zh) | 2013-03-14 | 2019-05-21 | 再生元醫藥公司 | 針對呼吸道融合病毒ｆ蛋白質的人類抗體及其使用方法 |
| WO2014179363A1 (en) | 2013-04-29 | 2014-11-06 | Adimab, Llc | Polyspecificity reagents, methods for their preparation and use |
| KR102188437B1 (ko) | 2014-01-15 | 2020-12-08 | 메디뮨 엘엘씨 | Rsv 특이적 항체 및 이의 기능적 부위 |
| AU2015340056A1 (en) * | 2014-10-27 | 2017-05-25 | Agency For Science, Technology And Research | Anti-TIM-3 antibodies |
| EP3529272A2 (en) | 2016-10-21 | 2019-08-28 | Adimab, LLC | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| KR102695416B1 (ko) | 2016-10-21 | 2024-08-13 | 아디맵 엘엘씨 | 항-호흡기 세포융합 바이러스 항체, 그리고 이의 생성 방법 및 사용 방법 |
| CA3040893A1 (en) | 2016-10-21 | 2018-04-26 | Adimab, Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
-
2017
- 2017-10-20 EP EP17794544.1A patent/EP3529272A2/en active Pending
- 2017-10-20 US US16/343,273 patent/US11479600B2/en active Active
- 2017-10-20 WO PCT/US2017/057708 patent/WO2018075954A2/en not_active Ceased
- 2017-10-20 JP JP2019521455A patent/JP7265984B2/ja active Active
-
2022
- 2022-04-13 JP JP2022066241A patent/JP2022087247A/ja not_active Withdrawn
- 2022-09-13 US US17/931,629 patent/US12215141B2/en active Active
-
2023
- 2023-09-08 JP JP2023146398A patent/JP7616813B2/ja active Active
- 2023-09-08 JP JP2023146397A patent/JP2023158193A/ja not_active Withdrawn
-
2025
- 2025-01-09 US US19/014,419 patent/US20250313612A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020518599A5 (enExample) | ||
| JP5808536B2 (ja) | 抗ｒｓｖｇタンパク質抗体 | |
| JP5734988B2 (ja) | Ｒｓｖ特異的結合分子 | |
| JP2018503361A5 (enExample) | ||
| JP2010528601A5 (enExample) | ||
| JP2018108086A5 (enExample) | ||
| JP2018506966A5 (enExample) | ||
| JP2012504955A5 (enExample) | ||
| JP2016512554A5 (enExample) | ||
| JP2011528902A5 (enExample) | ||
| JP2018535650A5 (enExample) | ||
| JP2015522252A5 (enExample) | ||
| FI3484915T3 (fi) | Uusia zikavirusepitooppeihin spesifisesti sitoutuvia vasta-aineita ja niiden käyttöjä | |
| JP2022065140A (ja) | 抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法 | |
| JP2016503413A5 (enExample) | ||
| JP2010516229A5 (enExample) | ||
| JP2014524748A5 (enExample) | ||
| RU2015136392A (ru) | Композиции и способы, основанные на нейтрализующих антителах, доставляемых интраназально, для улучшенной терапевтической эффективности | |
| JP2023538369A5 (enExample) | ||
| JP2022087247A (ja) | 抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法 | |
| JP2024520666A5 (enExample) | ||
| JP2020521797A5 (enExample) | ||
| JP2019531293A5 (enExample) | ||
| JP2018529661A5 (enExample) | ||
| JP2018533569A5 (enExample) |